DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.268 EUR
+0.05 (+0.84%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • CPR had positive earnings in the past year.
  • In the past year CPR had a positive cash flow from operations.
  • CPR had positive earnings in each of the past 5 years.
  • In the past 5 years CPR always reported a positive cash flow from operatings.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.27%, CPR is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
  • With a Return On Equity value of 8.97%, CPR perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
  • CPR has a Return On Invested Capital of 6.57%. This is in the better half of the industry: CPR outperforms 60.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.41%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR's Profit Margin of 11.35% is fine compared to the rest of the industry. CPR outperforms 60.71% of its industry peers.
  • In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
  • The Operating Margin of CPR (19.74%) is better than 64.29% of its industry peers.
  • CPR's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CPR (60.31%) is better than 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CPR.MI Health Analysis

2.1 Basic Checks

  • CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CPR has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CPR has more shares outstanding
  • CPR has a better debt/assets ratio than last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.65 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CPR's Altman-Z score of 2.65 is amongst the best of the industry. CPR outperforms 82.14% of its industry peers.
  • CPR has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as CPR would need 6.60 years to pay back of all of its debts.
  • The Debt to FCF ratio of CPR (6.60) is better than 67.86% of its industry peers.
  • CPR has a Debt/Equity ratio of 0.59. This is a neutral value indicating CPR is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.59, CPR is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.65
ROIC/WACC0.99
WACC6.6%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.22 indicates that CPR has no problem at all paying its short term obligations.
  • CPR has a Current ratio of 2.22. This is in the better half of the industry: CPR outperforms 78.57% of its industry peers.
  • A Quick Ratio of 0.96 indicates that CPR may have some problems paying its short term obligations.
  • CPR has a better Quick ratio (0.96) than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CPR.MI Growth Analysis

3.1 Past

  • CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
  • The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
  • The Revenue has decreased by -0.60% in the past year.
  • The Revenue has been growing by 11.48% on average over the past years. This is quite good.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
  • The Revenue is expected to grow by 4.37% on average over the next years.
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y11.26%
Revenue Next Year0.52%
Revenue Next 2Y2.5%
Revenue Next 3Y3.34%
Revenue Next 5Y4.37%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.61, CPR is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 60.71% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.91. CPR is around the same levels.
  • CPR is valuated rather expensively with a Price/Forward Earnings ratio of 19.89.
  • Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than 60.71% of the companies in the same industry.
  • CPR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.61
Fwd PE 19.89
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than 60.71% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than 60.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.88
EV/EBITDA 12.64
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CPR may justify a higher PE ratio.
PEG (NY)4.9
PEG (5Y)1.8
EPS Next 2Y8.37%
EPS Next 3Y9.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • CPR has a Yearly Dividend Yield of 1.59%. Purely for dividend investing, there may be better candidates out there.
  • CPR's Dividend Yield is slightly below the industry average, which is at 2.76.
  • CPR's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • CPR pays out 22.52% of its income as dividend. This is a sustainable payout ratio.
DP22.52%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (4/28/2026, 7:00:00 PM)

6.268

+0.05 (+0.84%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners50.82%
Ins Owner ChangeN/A
Market Cap7.72B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts73.33
Price Target7.3 (16.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.81%
PT rev (3m)3.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-3.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-2.12%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 19.89
P/S 2.53
P/FCF 19.88
P/OCF 11.22
P/B 2
P/tB 19.45
EV/EBITDA 12.64
EPS(TTM)0.29
EY4.63%
EPS(NY)0.32
Fwd EY5.03%
FCF(TTM)0.32
FCFY5.03%
OCF(TTM)0.56
OCFY8.91%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)4.9
PEG (5Y)1.8
Graham Number4.52368 (-27.83%)
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.65
F-Score8
WACC6.6%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y11.26%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year0.52%
Revenue Next 2Y2.5%
Revenue Next 3Y3.34%
Revenue Next 5Y4.37%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year24.97%
EBIT Next 3Y12.76%
EBIT Next 5Y9.26%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


How profitable is DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 21.61 and the Price/Book (PB) ratio is 2.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 4.41% in the next year.